Alnylam Pharmaceuticals, Inc. (ALNY)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 19.03B |
| Enterprise value | 17.96B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 9.42 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 21.89 |
| Enterprise value/EBITDA | -25.65 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.41 |
| 52-week change 3 | -27.03% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 218.88 |
| 52-week low 3 | 141.98 |
| 50-day moving average 3 | 149.38 |
| 200-day moving average 3 | 170.28 |
Share statistics
| Avg vol (3-month) 3 | 778.37k |
| Avg vol (10-day) 3 | 451.24k |
| Shares outstanding 5 | 126.49M |
| Implied shares outstanding 6 | 126.49M |
| Float 8 | 125.95M |
| % held by insiders 1 | 0.41% |
| % held by institutions 1 | 93.83% |
| Shares short (30 Apr 2024) 4 | 2.63M |
| Short ratio (30 Apr 2024) 4 | 5.37 |
| Short % of float (30 Apr 2024) 4 | 2.39% |
| Short % of shares outstanding (30 Apr 2024) 4 | 2.08% |
| Shares short (prior month 28 Mar 2024) 4 | 2.8M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -16.58% |
| Operating margin (ttm) | -8.79% |
Management effectiveness
| Return on assets (ttm) | -3.05% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 2B |
| Revenue per share (ttm) | 15.97 |
| Quarterly revenue growth (yoy) | 54.80% |
| Gross profit (ttm) | N/A |
| EBITDA | -122.3M |
| Net income avi to common (ttm) | -332.08M |
| Diluted EPS (ttm) | -2.63 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 2.37B |
| Total cash per share (mrq) | 18.75 |
| Total debt (mrq) | 2.68B |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 3.17 |
| Book value per share (mrq) | -1.73 |
Cash flow statement
| Operating cash flow (ttm) | 189.12M |
| Levered free cash flow (ttm) | 172.9M |
© 2024 Yahoo. All rights reserved.